Copyright
©The Author(s) 2021.
World J Diabetes. Sep 15, 2021; 12(9): 1576-1586
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1576
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1576
Figure 1 Network of evidence of included studies.
GLP-1: Glucagon-like peptide-1 receptor agonists; TZD: Thiazolidinediones; MET: Metformin; SGLT2: Sodium glucose cotransporter-2 inhibitors; PLA: Placebo; HFC: Hepatic fat content; NAS: Nonalcoholic fatty liver disease activity score; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Serum γ-glutamyl transferase.
- Citation: Huang YZ, Yang GY, Wang C, Chen XY, Zhang LL. Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis. World J Diabetes 2021; 12(9): 1576-1586
- URL: https://www.wjgnet.com/1948-9358/full/v12/i9/1576.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i9.1576